Download PDF
Thromb Haemost 1991; 65(05): 565-572
DOI: 10.1055/s-0038-1648191
Original Article
Schattauer GmbH Stuttgart

Stimulation of Tissue-Type Plasminogen Activator Synthesis by Retinoids in Cultured Human Endothelial Cells and Rat Tissues In Vivo

Teake Kooistra
The Gaubius Institute TNO, Leiden, The Netherlands
,
Jeannette P Opdenberg
The Gaubius Institute TNO, Leiden, The Netherlands
,
Karin Toet
The Gaubius Institute TNO, Leiden, The Netherlands
,
Henk F J Hendriks
*   The TNO Institute for Experimental Gerontology, Rijswijk, The Netherlands
,
Ria M van den Hoogen
The Gaubius Institute TNO, Leiden, The Netherlands
,
Jef J Emeis
The Gaubius Institute TNO, Leiden, The Netherlands
› Author Affiliations
Further Information

Publication History

Received 12 October 1990

Accepted after revision 22 January 1991

Publication Date:
24 July 2018 (online)

Also available at
  PDF Download  Permissions and Reprints

Summary

Tissue-type plasminogen activator (t-PA) and its inhibitor, plasminogen activator inhibitor 1 (PAI-1), play an important role in regulating the fibrinolytic capacity of plasma. Both t-PA and PAI-1 are synthesized by the endothelium. We report that retinoic acid (vitamin A acid) and other retinoids rather specifically stimulate the production of t-PA by cultured human umbilical vein endothelial cells. Effective retinoids induced a dose-dependent (range: 0.01-50 μM) increase in the production of t-PA of maximally about six-fold, while simultaneously causing no or only a small increase (less than two-fold) of PAI-1. The effects on t-PA synthesis were apparent by 4-8 h, and reached maximal values after about 24-48 h of incubation with retinoid. The retinoid effect on t-PA production was accompanied by increased t-PA mRNA levels, without any parallel change in PAI-1 or GAPDH mRNA concentrations. The study also shows that modifications at the carboxyl group of retinoic acid are associated with a decrease in stimulatory potency. The stimulatory pathway appears to be identical for all retinoids but distinct from a pathway by which another strong inducer, sodium butyrate, induces t-PA synthesis in endothelial cells. The induction of t-PA by retinoids might involve protein kinase C (PKC) as judged by an experiment using a specific PKC inhibitor.

The effect of retinoids on the fibrinolytic system in vivo was assessed by feeding rats with a vitamin A deficient diet or a diet with excess of vitamin A or other retinoids. The activity and antigen levels for t-PA in plasma and tissue samples were strongly decreased in vitamin A-starved animals, and enhanced in retinoid-fed animals. The recognition of a class of compounds, the retinoids, that can increase t-PA synthesis in cultured human endothelial cells and in rat tissues in vivo, may be of importance in designing an effective method to enhance plasma fibrinolytic activity, and thereby in preventing thrombotic phenomena.

 

  • References

  • 1 Wun T-C, Capuano A. Spontaneous fibrinolysis in whole human plasma. Identification of tissue activator-related protein as the major plasminogen activator causing spontaneous activity in vitro. J Biol Chem 1985; 260: 5061-5066
    PubMedGoogle Scholar
  • 2 Emeis JJ. Mechanisms involved in short-term changes in blood levels of t-PA. In: Tissue-type Plasminogen Activator (t-PA). Physiological and Clinical Aspects Kluft C. (Ed) CRC Press; Boca Raton, CA: 1988. vol II: pp 21-35
  • 3 Kooistra T. The use of cultured human endothelial cells and hepatocy-tes as an in vitro model system to study modulation of endogenous fibrinolysis. Fibrinolysis 1990; 4 suppl (Suppl. 02) 33-39
    PubMedGoogle Scholar
  • 4 Kooistra T, Van den Berg J, Tons A, Platenburg G, Rijken DC, Van den Berg E. Butyrate stimulates tissue-type plasminogen-activator synthesis in cultured human endothelial cells. Biochem J 1987; 247: 605-612
    CrossrefPubMedGoogle Scholar
  • 5 Kruh J. Effects of sodium butyrate, a new pharmacological agent, on cells in culture. Mol Cell Biochem 1982; 42: 65-82
    PubMedGoogle Scholar
  • 6 Kyritsis A, Joseph G, Chader GJ. Effects of butyrate, retinol, and retinoic acid on human Y-79 retinoblastoma cells growing in monolayer cultures. J Nat Cancer Inst 1984; 73: 649-654
    PubMedGoogle Scholar
  • 7 Leftwich JA, Hall RE. Enhancement of phorbol diester-induced HL-60-mediated cytotoxicity by retinoic acid, dimethyl sulfoxide, and 5-azacytidine. Cancer Res 1986; 46: 3789-3792
    PubMedGoogle Scholar
  • 8 Bijman JTh, Wagener DJTh, Van Rennes H, Wessels JMC, Ramaekers FCS, Van den Broek R. Modulation of placental alkaline phosphatase activity and cytokeratins in human HN-1 cells by butyrate, retinoic acid, catecholamines and histamine. Br J Cancer 1987; 56: 127-132
    CrossrefPubMedGoogle Scholar
  • 9 Malik H, Nordenberg J, Novogrodsky A, Fuchs A, Malik Z. Chemical inducers of differentiation, dimethylsulfoxide, butyric acid, and dimethylthiourea, induce selective ultrastructural patterns in B16 melanoma cells. Bio Cell 1987; 60: 33-40
    CrossrefPubMedGoogle Scholar
  • 10 Nelson NF, Cieplak W, Dacus SC, Prager MD. Modulation of secreted plasminogen activator activity of human renal carcinoma cells by dimethylsulfoxide, butyrate and retinoate. Cancer Lett 1987; 34: 305-316
    CrossrefPubMedGoogle Scholar
  • 11 Meyskens Jr FL, Goodman GE, Alberts DS. 13-Cis-retinoic acid: pharmacology, toxicology, and clinical applications for the prevention and treatment of human cancer. CRC Crit Rev Oncol Hematol 1985; 3: 75-101
    CrossrefPubMedGoogle Scholar
  • 12 Kluft C, Van Wezel AL, Van der Velden CAM, Emeis JJ, Verheijen JH, Wijngaards G. Large-scale production of extrinsic (tissue-type) plasminogen activator from human melanoma cells. In: Advances in Biotechnological Processes Mizrahi A, Van Wezel AL. (eds) Alan R. Liss Inc; New York: 1983. pp 97-110
  • 13 Gaffney PJ, Curtis AD. A collaborative study of a proposed international standard for tissue plasminogen activator (t-PA). Thromb Haemostas 1985; 53: 134-136
    PubMedGoogle Scholar
  • 14 Jaffe EA, Nachman RL, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical cord veins. Identification by morphologic and immunologic criteria. J Clin Invest 1973; 52: 2745-2756
    CrossrefPubMedGoogle Scholar
  • 15 Maciag T, Cerundolo J, Ilsley S, Kelley PR, Forand R. An endothelial cell growth factor from bovine hypothalamus: identification and partial characterization. Proc Natl Acad Sci USA 1979; 76: 5674-5678
    CrossrefPubMedGoogle Scholar
  • 16 Van Hinsbergh VWM, Havekes L, Emeis JJ, Van Corven E, Scheffer M. Low density lipoprotein metabolism by endothelial cells from human umbilical cord arteries and veins. Arteriosclerosis 1983; 3: 547-559
    CrossrefPubMedGoogle Scholar
  • 17 Hollander CF. Current experience using the laboratory rat in aging studies. Lab Animal Sci 1976; 26: 320-328
    PubMedGoogle Scholar
  • 18 Padrö T, Van den Hoogen CM, Emeis JJ. Distribution of tissue-type plasminogen activator (activity and antigen) in rat tissues. Blood Coag Fibrinol 1990; 1: 601-608
    PubMedGoogle Scholar
  • 19 Verheijen JH, Mullaart E, Chang GTG, Kluft C, Wijngaards GA. A simple, sensitive spectrophotometric assay for extrinsic (tissue-type) plasminogen activator applicable to measurements in plasma. Thromb Haemostas 1982; 48: 266-269
    PubMedGoogle Scholar
  • 20 Verheijen JH, Chang GTG, Kluft C. Evidence for the occurrence of a fast-acting inhibitor for tissue-type plasminogen activator in human plasma. Thromb Haemostas 1984; 51: 392-395
    PubMedGoogle Scholar
  • 21 Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-159
    PubMedGoogle Scholar
  • 22 Maniatis T, Fritsch EF, Sambrook J. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory 1982. ISBN 0-87969-136-0
    Google Scholar
  • 23 Church GM, Gilbert W. Genomic sequencing. Proc Natl Acad Sci USA 1984; 81: 1991-1995
    CrossrefPubMedGoogle Scholar
  • 24 Van Zonneveld AJ, Chang GTG, Van den Berg J, Kooistra T, Verheijen JH, Pannekoek H, Kluft C. Quantification of tissue-type plasminogen activator (t-PA) mRNA in human endothelial-cell cultures by hybridization with a t-PA cDNA probe. Biochem J 1986; 235: 385-390
    CrossrefPubMedGoogle Scholar
  • 25 Van den Berg EA, Sprengers ED, Jaye M, Burgess W, Maciag T, Van Hinsbergh VWM. Regulation of plasminogen activator inhibitor-1 mRNA in human endothelial cells. Thromb Haemostas 1988; 60: 63-67
    PubMedGoogle Scholar
  • 26 Fort P, Marty L, Piechaczyk M, El Sabrouty S, Dani C, Jeanteur P, Blanchard JM. Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family. Nucl Acid Res 1985; 13: 1431-1442
    CrossrefPubMedGoogle Scholar
  • 27 Offringa R, Smits AMM, Houweling A, Bos JL, Van der Eb AJ. Similar effects of adenovirus E1A and glucocorticoid hormones on the expression of the metallo-protease stromelysin. Nucl Acid Res 1988; 16: 10973-10984
    CrossrefPubMedGoogle Scholar
  • 28 Levin EG. Quantitation and properties of the active and latent plasminogen activator inhibitors in cultures of human endothelial cells. Blood 1986; 67: 1309-1313
    PubMedGoogle Scholar
  • 29 Alessi MC, Juhan-Vague I, Kooistra T, Declerck PJ, Collen D. Insulin stimulates the synthesis of plasminogen activator inhibitor 1 by the human hepatocellular cell line Hep G2. Thromb Haemostas 1988; 60: 491-494
    PubMedGoogle Scholar
  • 30 Ohkubo S, Yamada E, Eudo T, Itok H, Hidaka H. Vitamin A induced activation of Ca2+-activated, phospholipid-dependent protein kinase (“C” kinase). Biochem Biophys Res Commun 1983; 114: 1194-1199
    CrossrefPubMedGoogle Scholar
  • 31 Zylber-Katz E, Glazer RI. Phospholipid Ca2+-dependent protein kinase activity and protein phosphorylation patterns in the differentiation of human promyelocytic leukemia cell line HL-60. Cancer Res 1985; 45: 5159-5164
    PubMedGoogle Scholar
  • 32 Isakov N. Regulation of T-cell-derived protein kinase C activity by vitamin A derivatives. Cell Immunol 1988; 115: 288-298
    CrossrefPubMedGoogle Scholar
  • 33 Levin EG, Marotti KR, Santell L. Protein kinase C and the stimulation of tissue plasminogen activator release from human endothelial cells. Dependence on the elevation of messenger RNA. J Biol Chem 1989; 264: 16030-16036
    PubMedGoogle Scholar
  • 34 Inada Y, Hagiwara H, Kojima S, Shimonaka M, Saito Y. Synergism of vitamins A and C on fibrinolysis. Biochem Biophys Res Commun 1985; 130: 182-187
    CrossrefPubMedGoogle Scholar
  • 35 Kooistra T, Hendriks HFJ, Emeis JJ. Stimulation of tissue-type plasminogen activator synthesis by retinoids in cultured human endothelial cells and rat tissues in vivo. Fibrinolysis 1990; 4 (suppl) (Suppl. 03) 126
    PubMedGoogle Scholar
  • 36 Thompson EA, Van Nuffelen A, Nelles L, Collen D. Stimulation of human tissue-type plasminogen activator (t-PA) synthesis by retinoic acid. Role of protein kinase C and of t-PA genomic elements. Fibrinolysis 1990; 4 (suppl) (Suppl. 03) 163
    PubMedGoogle Scholar
  • 37 Strickland S, Breitman TR, Frickel F, Nuerrenbach A, Haedicke E, Spom MB. Structure-activity relationship of a new series of retinoidal benzoic acid derivatives as measured by induction of differentiation of murine F9 teratocarcinoma cells and human HL-60 promyelocytic leukemia cells. Cancer Res 1983; 43: 5268-5272
    PubMedGoogle Scholar
  • 38 Tobler A, Dawson MI, Koeffler HP. Retinoids. Structure-function relationship in normal and leukemic hematopoiesis in vitro. J Clin Invest 1986; 78: 303-309
    CrossrefPubMedGoogle Scholar
  • 39 Wilson EL, Francis GE. Differentiation-linked secretion of urokinase and tissue plasminogen activator by normal human hemopoietic cells. J Exp Med 1987; 165: 1609-1623
    CrossrefPubMedGoogle Scholar
  • 40 Rickies RJ, Darrow AL, Strickland S. Differentiation-responsive elements in the 5’ region of the mouse tissue plasminogen activator gene confer two-stage regulation by retinoic acid and cyclic AMP in teratocarcinoma cells. Mol Cell Biol 1989; 9: 1691-1704
    CrossrefPubMedGoogle Scholar
  • 41 Yukioka M, Sasaki S, Le Qi S, Inova A. Two species of histone acetyltransferase in rat liver nuclei. J Biol Chem 1984; 259: 8372-8377
    PubMedGoogle Scholar
  • 42 Chytil F. Retinoic acid: biochemistry, pharmacology, toxicology, and therapeutic use. Pharmac Rev 1984; 36: 939-1005
    PubMedGoogle Scholar
  • 43 Maden M, Ong DE, Summerbell D, Chytil F. Spatial distribution of cellular protein binding to retinoic acid in the chick limb bud. Nature (London) 1988; 335: 733-735
    CrossrefPubMedGoogle Scholar
  • 44 Chytil F, Ong DE. Cellular retinoid-binding proteins. In: The Retinoids Spom BM, Roberts AB, Goodman DS. (eds) Academic Press; New York: 1984. Vol 2, Chapter 9, pp 89-123
  • 45 Evans RM. The steroid and thyroid hormone receptor superfamily. Science 1988; 240: 889-895
    CrossrefPubMedGoogle Scholar
  • 46 Green S, Chambon P. Nuclear receptors enhance our understanding of transcription regulation. TIG 1988; 4: 309-314
    CrossrefPubMedGoogle Scholar
  • 47 Petkovich M, Brand NJ, Krust A, Chambon P. A human retinoic acid receptor which belongs to the family of nuclear receptors. Nature (London) 1987; 330: 444-450
    CrossrefPubMedGoogle Scholar
  • 48 Brand N, Petkovich M, Krust A, Chambon P, De Thé H, Marchio A, Tiollais P, Dejean A. Identification of a second human retinoic acid receptor. Nature (London) 1988; 332: 850-853
    CrossrefPubMedGoogle Scholar
  • 49 Krust A, Kastner Ph, Petkovich M, Zelent A, Chambon P. A third human retinoic acid receptor, hRAR-γ. Proc Natl Acad Sci USA 1989; 86: 5310-5314
    CrossrefPubMedGoogle Scholar